While celiac disease fulfills several WHO criteria for mass screening, such as high prevalence, available treatment and difficult clinical detection, it remains unproven that treatment of asymptomatic celiac disease can lower the risk of severe complications and improve quality of life, or that it is cost-effective.
A research team recently set out to review the literature on screening for celiac disease in relation to the current World Health Organization (WHO) criteria for mass screening.
The team included Jonas F Ludvigsson, Timothy R Card, Katri Kaukinen, Julio Bai, Fabiana Zingone, David S Sanders, and Joseph A Murray.
The research...
- Read Full Article...
- 1 comment
- 4,637 views
